195 related articles for article (PubMed ID: 25668688)
1. Prognostic value of components of body composition in patients treated with targeted therapy for advanced renal cell carcinoma: a retrospective case series.
Gu W; Zhu Y; Wang H; Zhang H; Shi G; Liu X; Ye D
PLoS One; 2015; 10(2):e0118022. PubMed ID: 25668688
[TBL] [Abstract][Full Text] [Related]
2. Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study.
Wang J; Dong P; Qu Y; Xu W; Zhou Z; Ning K; Peng Y; Xiong L; Li Z; Zou X; Liu Z; Li M; He Z; Luo J; Tian X; Zhang H; Guo S; Han H; Zhou F; Yin S; Ye D; Yu C; Zhang Z
Eur Radiol; 2023 May; 33(5):3232-3242. PubMed ID: 36538073
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.
Maurits JSF; Sedelaar JPM; Mulders PFA; Aben KKH; Kiemeney LALM; Vrieling A
Clin Nutr; 2022 Jan; 41(1):131-143. PubMed ID: 34872047
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy.
Lee HW; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Int J Urol; 2015 May; 22(5):455-61. PubMed ID: 25631365
[TBL] [Abstract][Full Text] [Related]
6. Visceral obesity in predicting oncologic outcomes of localized renal cell carcinoma.
Park YH; Lee JK; Kim KM; Kook HR; Lee H; Kim KB; Lee S; Byun SS; Lee SE
J Urol; 2014 Oct; 192(4):1043-9. PubMed ID: 24704011
[TBL] [Abstract][Full Text] [Related]
7. The Association of Body Composition Parameters Measured by Computed Tomography with Cancer Stage, Prognosis, and Survival in Patients with Renal Cell Carcinoma.
Gur Ozcan SG; Barali D; Erkan A
Curr Med Imaging; 2024; 20(1):e15734056301569. PubMed ID: 38544394
[TBL] [Abstract][Full Text] [Related]
8. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
Antoun S; Lanoy E; Iacovelli R; Albiges-Sauvin L; Loriot Y; Merad-Taoufik M; Fizazi K; di Palma M; Baracos VE; Escudier B
Cancer; 2013 Sep; 119(18):3377-84. PubMed ID: 23801109
[TBL] [Abstract][Full Text] [Related]
10. Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma.
Kaneko G; Miyajima A; Yuge K; Yazawa S; Mizuno R; Kikuchi E; Jinzaki M; Oya M
Jpn J Clin Oncol; 2015 Feb; 45(2):210-6. PubMed ID: 25420691
[TBL] [Abstract][Full Text] [Related]
11. Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy.
Mizuno R; Miyajima A; Hibi T; Masuda A; Shinojima T; Kikuchi E; Jinzaki M; Oya M
Med Oncol; 2017 Apr; 34(4):47. PubMed ID: 28213730
[TBL] [Abstract][Full Text] [Related]
12. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
[TBL] [Abstract][Full Text] [Related]
13. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade.
Hu Z; Wu J; Lai S; Xu Y; Zhan J; Li R; Liu X; Wang N; Wei X; Jiang X; Yang R
Eur Radiol; 2020 Jul; 30(7):3977-3986. PubMed ID: 32144457
[TBL] [Abstract][Full Text] [Related]
14. Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.
Kim SH; Kim JK; Park EY; Joo J; Lee KH; Seo HK; Joung JY; Chung J
PLoS One; 2019; 14(2):e0211105. PubMed ID: 30785902
[TBL] [Abstract][Full Text] [Related]
15. Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma.
Du Y; Yang W; Liu H; Qin C; Tang X; Xu T
Clin Genitourin Cancer; 2022 Feb; 20(1):e75-e80. PubMed ID: 34802967
[TBL] [Abstract][Full Text] [Related]
16. Increased visceral adipose tissue in clear cell renal cell carcinoma with and without peritumoral collateral vessels.
Greco F; Quarta LG; Grasso RF; Beomonte Zobel B; Mallio CA
Br J Radiol; 2020 Aug; 93(1112):20200334. PubMed ID: 32516557
[TBL] [Abstract][Full Text] [Related]
17. Significance of preoperative prognostic nutrition index as prognostic predictors in patients with metastatic renal cell carcinoma with tyrosine kinase inhibitors as first-line target therapy.
Cai W; Zhong H; Kong W; Dong B; Chen Y; Zhou L; Xue W; Huang Y; Zhang J; Huang J
Int Urol Nephrol; 2017 Nov; 49(11):1955-1963. PubMed ID: 28889323
[TBL] [Abstract][Full Text] [Related]
18. Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma.
Ishihara H; Nishimura K; Ikeda T; Fukuda H; Yoshida K; Iizuka J; Kondo T; Takagi T
Urol Oncol; 2024 Sep; 42(9):291.e27-291.e37. PubMed ID: 38653590
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
[TBL] [Abstract][Full Text] [Related]
20. Increased visceral adipose tissue in male patients with non-clear cell renal cell carcinoma.
Greco F; Mallio CA; Grippo R; Messina L; Vallese S; Rabitti C; Quarta LG; Grasso RF; Beomonte Zobel B
Radiol Med; 2020 Jun; 125(6):538-543. PubMed ID: 32067162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
